Rory Stark
Rory Stark
University of Cambridge, Cancer Research UK Cambridge Institute
Verified email at cruk.cam.ac.uk
Title
Cited by
Cited by
Year
Differential oestrogen receptor binding is associated with clinical outcome in breast cancer
CS Ross-Innes, R Stark, AE Teschendorff, KA Holmes, HR Ali, ...
Nature 481 (7381), 389-393, 2012
10802012
The androgen receptor fuels prostate cancer by regulating central metabolism and biosynthesis
CE Massie, A Lynch, A Ramos‐Montoya, J Boren, R Stark, L Fazli, ...
The EMBO journal 30 (13), 2719-2733, 2011
4722011
Progesterone receptor modulates ERα action in breast cancer
H Mohammed, IA Russell, R Stark, OM Rueda, TE Hickey, GA Tarulli, ...
Nature 523 (7560), 313-317, 2015
4642015
Piwi and piRNAs act upstream of an endogenous siRNA pathway to suppress Tc3 transposon mobility in the Caenorhabditis elegans germline
PP Das, MP Bagijn, LD Goldstein, JR Woolford, NJ Lehrbach, ...
Molecular cell 31 (1), 79-90, 2008
3862008
The androgen receptor induces a distinct transcriptional program in castration-resistant prostate cancer in man
NL Sharma, CE Massie, A Ramos-Montoya, V Zecchini, HE Scott, ...
Cancer cell 23 (1), 35-47, 2013
3192013
GATA3 acts upstream of FOXA1 in mediating ESR1 binding by shaping enhancer accessibility
V Theodorou, R Stark, S Menon, JS Carroll
Genome research 23 (1), 12-22, 2013
2782013
Cooperative interaction between retinoic acid receptor-α and estrogen receptor in breast cancer
CS Ross-Innes, R Stark, KA Holmes, D Schmidt, C Spyrou, R Russell, ...
Genes & development 24 (2), 171-182, 2010
2402010
RNA sequencing: the teenage years
R Stark, M Grzelak, J Hadfield
Nature Reviews Genetics 20 (11), 631-656, 2019
2212019
DiffBind: differential binding analysis of ChIP-Seq peak data
R Stark, G Brown
R package version 100, 4-3, 2011
2162011
Independence of repressive histone marks and chromatin compaction during senescent heterochromatic layer formation
T Chandra, K Kirschner, JY Thuret, BD Pope, T Ryba, S Newman, ...
Molecular cell 47 (2), 203-214, 2012
2152012
BayesPeak: Bayesian analysis of ChIP-seq data
C Spyrou, R Stark, AG Lynch, S Tavaré
BMC bioinformatics 10 (1), 299, 2009
1462009
Integration of copy number and transcriptomics provides risk stratification in prostate cancer: a discovery and validation cohort study
H Ross-Adams, AD Lamb, MJ Dunning, S Halim, J Lindberg, CM Massie, ...
EBioMedicine 2 (9), 1133-1144, 2015
1412015
Impact of artifact removal on ChIP quality metrics in ChIP-seq and ChIP-exo data
TS Carroll, Z Liang, R Salama, R Stark, I de Santiago
Frontiers in genetics 5, 75, 2014
1242014
Latent regulatory potential of human-specific repetitive elements
MC Ward, MD Wilson, NL Barbosa-Morais, D Schmidt, R Stark, Q Pan, ...
Molecular cell 49 (2), 262-272, 2013
662013
5-hydroxymethylcytosine marks promoters in colon that resist DNA hypermethylation in cancer
S Uribe-Lewis, R Stark, T Carroll, MJ Dunning, M Bachman, Y Ito, L Stojic, ...
Genome biology 16 (1), 1-15, 2015
602015
BayesPeak—an R package for analysing ChIP-seq data
J Cairns, C Spyrou, R Stark, ML Smith, AG Lynch, S Tavaré
Bioinformatics 27 (5), 713-714, 2011
482011
Nuclear ARRB 1 induces pseudohypoxia and cellular metabolism reprogramming in prostate cancer
V Zecchini, B Madhu, R Russell, N Pértega‐Gomes, A Warren, E Gaude, ...
The EMBO journal 33 (12), 1365-1382, 2014
472014
Choline kinase alpha as an androgen receptor chaperone and prostate cancer therapeutic target
M Asim, CE Massie, F Orafidiya, N Pértega-Gomes, AY Warren, ...
JNCI: Journal of the National Cancer Institute 108 (5), 2016
252016
The ETS family member GABPα modulates androgen receptor signalling and mediates an aggressive phenotype in prostate cancer
NL Sharma, CE Massie, F Butter, M Mann, H Bon, A Ramos-Montoya, ...
Nucleic acids research 42 (10), 6256-6269, 2014
252014
Genome-scale validation of deep-sequencing libraries
D Schmidt, R Stark, MD Wilson, GD Brown, DT Odom
PLoS One 3 (11), e3713, 2008
212008
The system can't perform the operation now. Try again later.
Articles 1–20